Read More Pharma Industry News Tiziana Life Sciences strengthens intranasal foralumab development with Renaissance Lakewood partnership Tiziana Life Sciences, Ltd. (Nasdaq: TLSA), a clinical-stage biotechnology company focused on immunomodulation therapies, has announced a strategic… byPallavi MadhirajuFebruary 23, 2025